Expression Edits is a biotechnology company that leverages AI-driven intronization technology to enhance protein expression, addressing the challenges of producing proteins for therapeutic applications. By modernizing the genetic toolbox, they aim to unlock previously unattainable proteins, utilizing their Genetic Syntax Engine to optimize transgenic designs. Their innovative approach positions them as a leader in the field, with a focus on developing high-value protein therapeutics and supporting gene therapy optimization. The company is actively seeking collaborations to further explore the potential of their technology in gene therapy applications, indicating a strong market position and growth potential.

Cambridge, UK

Haverhill, UK

ExpressionEdits

BlueYard invests in founders with transforming ideas that decentralize markets, empower users and liberate data

BY Capital Management GmbH

BlueYard Capital

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Hello,
In 5 quick steps, tell us about the type of opportunities you'd be interested in next. We'll use this information to connect you to relevant opportunities in the BlueYard Capital network as they come up. You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a BlueYard Capital company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Explore open positions at BlueYard portfolio companies

Is this your company?